A randomized clinical trial of metacognitive therapy and nortriptyline for anxiety, depression, and difficulties in emotion regulation of patients with functional dyspepsia
- PMID: 33024721
- PMCID: PMC7513609
- DOI: 10.4081/ripppo.2020.448
A randomized clinical trial of metacognitive therapy and nortriptyline for anxiety, depression, and difficulties in emotion regulation of patients with functional dyspepsia
Abstract
Functional Dyspepsia (FD) as a psychosomatic disorder is an upper gastrointestinal tract disease without organic pathogenesis causes. The psychopathological nature of this disease and its high correlation with anxiety and depression implies the need for psychological interventions. The purpose of the present study is to compare the efficacy of Metacognitive Therapy (MCT) and medication for the symptoms of anxiety, depression, and difficulties in emotion regulation in patients with FD. In a randomized clinical trial, 65 patients with FD were recruited during their visit to gastroenterology clinics. These patients were randomly assigned to three groups to receive MCT, nortriptyline treatment, and controls. They were treated for 10 weeks and followed up three months later. The instruments used in this study were Hamilton anxiety and Depression Rating Scale (HAM-A and HDRS) and difficulties in emotion regulation scale. The results were analyzed using repeated measure analysis by SPSS (19- IBM). Data analysis showed statistically significant differences in the variables of depression, anxiety among MCT, nortriptyline treatment, and controls at pre-test, post-test and follow-up phases. Moreover, MCT had a better and more persistent effect on anxiety compared to nortriptyline treatment, as well as a better efficacy in treating anxiety and depression symptoms compared to the controls. MCT demonstrated better efficacy in treating anxiety symptoms compared to nortriptyline treatment and controls.
Keywords: anxiety; depression; dyspepsia; emotion; psychotherapy.
©Copyright: the Author(s).
Conflict of interest statement
Conflict of interest: the authors declare no potential conflict of interest. Ethical approval and consent to participate: the code of ethics IR.SBMU.MSP.REC.1396.756. Furthermore, the study was registered (2019) with the IID: IRCT20190312043036N1.
Figures
Similar articles
-
Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia - a randomized clinical trial.Front Psychiatry. 2024 Jan 16;14:1297231. doi: 10.3389/fpsyt.2023.1297231. eCollection 2023. Front Psychiatry. 2024. PMID: 38293596 Free PMC article.
-
Comparison of the potency of nortriptyline and mirtazapine on gastrointestinal symptoms, the level of anxiety and depression in patients with functional dyspepsia.Gastroenterol Hepatol Bed Bench. 2023;16(1):468-477. doi: 10.22037/ghfbb.v16i1.2513. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37070114 Free PMC article.
-
Clinical Trial: Efficacy of Mosapride Controlled-release and Nortriptyline in Patients With Functional Dyspepsia: A Multicenter, Double-placebo, Double-blinded, Randomized Controlled, Parallel Clinical Study.J Neurogastroenterol Motil. 2024 Jan 30;30(1):106-115. doi: 10.5056/jnm23147. J Neurogastroenterol Motil. 2024. PMID: 38173162 Free PMC article.
-
Association of Functional Dyspepsia with Depression and Anxiety: A Systematic Review.J Gastrointestin Liver Dis. 2021 Jun 18;30(2):259-266. doi: 10.15403/jgld-3325. J Gastrointestin Liver Dis. 2021. PMID: 33951117
-
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2021 Jan 18;1(1):CD013011. doi: 10.1002/14651858.CD013011.pub2. Cochrane Database Syst Rev. 2021. PMID: 33460048 Free PMC article.
Cited by
-
Going 'meta': a systematic review of metacognition and functional neurological disorder.Brain Commun. 2025 Jan 13;7(1):fcaf014. doi: 10.1093/braincomms/fcaf014. eCollection 2025. Brain Commun. 2025. PMID: 39882021 Free PMC article. Review.
-
The Influence of Psychological Status on Acupuncture for Postprandial Distress Syndrome: A Subgroup Analysis of a Multicenter, Randomized Controlled Trial.Evid Based Complement Alternat Med. 2022 Jan 31;2022:1614648. doi: 10.1155/2022/1614648. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35140795 Free PMC article.
-
British Society of Gastroenterology guidelines on the management of functional dyspepsia.Gut. 2022 Sep;71(9):1697-1723. doi: 10.1136/gutjnl-2022-327737. Epub 2022 Jul 7. Gut. 2022. PMID: 35798375 Free PMC article.
References
-
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). DSM-5®. American Psychiatric Pub.
-
- Aro P., Talley N. J., Ronkainen J., Storskrubb T., Vieth M., Johansson S. E., Boiling-sternevald L., Agréus L. (2009). Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population- based study. Gastroenterology, 137(1), 94-100. - PubMed
-
- Bagherian R., Pourkazem T., Nouri A., Adibi P. (2009). The effects of stress management training on symptoms of medical treatment-resistant functional dyspepsia. Govaresh, 14(1), 15-22.
-
- Calvert E. L., Houghton L. A., Cooper P., Morris J., Whorwell P. J. (2002). Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology, 123(6), 1778-1785. - PubMed
LinkOut - more resources
Full Text Sources